Press Releases

CEO Note - Clinical Study Update and a Review of 2016 Accomplishments

Passage of the 21st Century Cures Act and its Potential Implications on Biodefense

Aethlon Announces Initiation of Sepsis-Related Virus Study

Aethlon Medical Announces Fiscal 2017 Second Quarter Results

Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016

Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation

Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum

Aethlon Medical Updates Corporate Presentation Schedule

Aethlon Medical To Present At The Rodman & Renshaw 18th Annual Global Investment Conference On September 13, 2016

The Dilemma in Funding Zika and Other Pandemic Therapies